Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. A landmark study published in The Lancet Infectious Diseases confirms that the benefits of combining the RTS,S malaria vaccine with antimalarial drugs in settings of highly seasonal malaria transmission continue over five years.
    Published: August 2023
  2. PATH’s Kim Green writes about how PATH is breaking down long-existing funding siloes and focusing instead on integrated services and systems.
    Published: August 2023
  3. According to the World Health Organization, self-care was recognized in the 1980s to bridge the gap in gender inequalities in health. Fiona Walugembe, Project Director at PATH Uganda, spoke to Monitor about self-care in women’s reproductive health
    Published: July 2023
  4. Learn about a new point-of-care test, developed by SD Biosensor and PATH, that could identify a hereditary condition that can cause hemolytic anemia in those who take tafenoquine.
    Published: July 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release